Drugs in Development
All Data
Our shared vision is to have a World, free of Pain.
Lead Product(s): Teriparatide
Therapeutic Area: Musculoskeletal Product Name: Tetridar
Highest Development Status: Approved Product Type: Peptide
Partner/Sponsor/Collaborator: Teva Pharmaceutical Industries
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement September 18, 2020
Details:
Grünenthal and Teva have reached an exclusive agreement for the marketing, distribution, and promotion of teriparatide (Tetridar) in the Spanish market.
Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE
Lead Product(s): Chondroitin Sulfate,Glucosamine Sulfate,Hyaluronic Acid
Therapeutic Area: Musculoskeletal Product Name: Condrovet
Highest Development Status: Approved Product Type: Small molecule
Partner/Sponsor/Collaborator: Bioiberica SA
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement June 09, 2020
Details:
Under the terms of the agreement, Bayer Animal Health will distribute and market selected products from Bioiberica´s Companion Animal Health portfolio in eight countries.
Market Place
Active Pharmaceutical Ingredients
Finished Drug Formulations
Price
Excipients
Services
Marketplace
